Future investigations should leverage the pleiotropy of GLP-1RAs to evaluate their effectiveness in treating multimorbidities, rather than focusing on a single health condition, particularly where obesity or other mechanistic pathways affected by GLP-1RAs are leading drivers, the authors write in their paper
EEM is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis
What is the "Skinny Shot?" Both semaglutide and tirzepatide have been referred to as "the skinny shot," as they are both administered as weekly shots, and both are effective parts of weight loss and weight maintenance regimens
F., Mahmoudi M., Wang Z., Wang R
This regulatory development is highly relevant to industry as it signals a shift toward more integrated and technology-driven weight management approaches and chronic disease prevention strategies In this space, Kelker Pharma recently introduced Nutrilinq Genesis, touted as the first science-backed nutritional support system for GLP-1 therapy patients